Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Paredes

Showing results (11-20 of 309) with videos related to

Pageof 31
Sort By:
Archivos De Bronconeumologia|May 2, 2022
New Antivirals and Immune Therapies for COVID-19 InfectionJose M Miro, Antoni Torres, Roger Paredes
Current Opinion in HIV and AIDS|July 27, 2012
Next-generation sequencing to assess HIV tropismLuke C Swenson, Martin Däumer, Roger Paredes
Retrovirology|November 29, 2024
Exploring potential associations between the human microbiota and reservoir of latent HIVNel Marín-Sánchez, Roger Paredes, Alessandra Borgognone
Lancet (London, England)|November 11, 2023
Classifying necrotising mpox as an AIDS-defining conditionOriol Mitjà, Roger Paredes, Brenda Cabtree, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 14, 2024
'Vagus Nerve Dysfunction in the Post-COVID-19 Condition' - Author's replyGemma Lladós, Marta Massanella, Roger Paredes, et al.
Current Drug Targets. Infectious Disorders|December 8, 2004
Advances in adjuvant therapy against acute bacterial meningitisVirginia Pomar, Sergi Martínez, Roger Paredes, et al.
The Lancet. Infectious Diseases|March 16, 2005
Disseminated cryptococcosis resembling milliary tuberculosis in an HIV-1-infected patientVirginia Pomar, Gemma Carrera, Roger Paredes, et al.
Current Opinion in Infectious Diseases|December 16, 2014
Transmission of HIV drug resistance: lessons from sensitive screening assaysAnna Maria Geretti, Roger Paredes, Michael J Kozal
Antiviral Therapy|September 25, 2023
HIV drug resistance in the era of contemporary antiretroviral therapy: A clinical perspectiveAndrew Carr, Nicola E Mackie, Roger Paredes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2005
Compromised immunologic recovery in treatment-experienced patients with HIV infection receiving both tenofovir disoproxil fumarate and didanosine in the TORO studiesEugènia Negredo, Anna Bonjoch, Roger Paredes, et al.
Pageof 31

Showing results (11-20 of 309) with videos related to

Sort By:
Pageof 31
Archivos De Bronconeumologia|May 2, 2022
New Antivirals and Immune Therapies for COVID-19 InfectionJose M Miro, Antoni Torres, Roger Paredes
Current Opinion in HIV and AIDS|July 27, 2012
Next-generation sequencing to assess HIV tropismLuke C Swenson, Martin Däumer, Roger Paredes
Retrovirology|November 29, 2024
Exploring potential associations between the human microbiota and reservoir of latent HIVNel Marín-Sánchez, Roger Paredes, Alessandra Borgognone
Lancet (London, England)|November 11, 2023
Classifying necrotising mpox as an AIDS-defining conditionOriol Mitjà, Roger Paredes, Brenda Cabtree, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 14, 2024
'Vagus Nerve Dysfunction in the Post-COVID-19 Condition' - Author's replyGemma Lladós, Marta Massanella, Roger Paredes, et al.
Current Drug Targets. Infectious Disorders|December 8, 2004
Advances in adjuvant therapy against acute bacterial meningitisVirginia Pomar, Sergi Martínez, Roger Paredes, et al.
The Lancet. Infectious Diseases|March 16, 2005
Disseminated cryptococcosis resembling milliary tuberculosis in an HIV-1-infected patientVirginia Pomar, Gemma Carrera, Roger Paredes, et al.
Current Opinion in Infectious Diseases|December 16, 2014
Transmission of HIV drug resistance: lessons from sensitive screening assaysAnna Maria Geretti, Roger Paredes, Michael J Kozal
Antiviral Therapy|September 25, 2023
HIV drug resistance in the era of contemporary antiretroviral therapy: A clinical perspectiveAndrew Carr, Nicola E Mackie, Roger Paredes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2005
Compromised immunologic recovery in treatment-experienced patients with HIV infection receiving both tenofovir disoproxil fumarate and didanosine in the TORO studiesEugènia Negredo, Anna Bonjoch, Roger Paredes, et al.
Pageof 31